Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma.

Flunarizine, a diphenylpiperazine calcium channel blocker, is known to increase tumor blood flow. It also interferes with calmodulin function, repair of DNA damage and drug resistance associated with P-glycoprotein. Flunarizine was tested for its ability to modulate either cyclophosphamide- or melph...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellino, S. M., Friedman, H. S., Elion, G. B., Ong, E. T., Marcelli, S. L., Page, R., Bigner, D. D., Dewhirst, M. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033851/
https://www.ncbi.nlm.nih.gov/pubmed/7779708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033851/
https://www.ncbi.nlm.nih.gov/pubmed/7779708

Ejemplares similares